Correlations of serum phosphoglycerate mutase family member 5 and YT521-B homology N6-methyladenosine RNA binding protein 2 levels with ventricular remodeling and prognosis in patients with heart failure with preserved ejection fraction

YU Fulin; HUANG Jiangbo; NING Yangshan

doi:10.7619/jcmp.20244630

Journal of Clinical Medicine in Practice > 2025 > 29(5): 64-69. > DOI: 10.7619/jcmp.20244630

YU Fulin, HUANG Jiangbo, NING Yangshan. Correlations of serum phosphoglycerate mutase family member 5 and YT521-B homology N6-methyladenosine RNA binding protein 2 levels with ventricular remodeling and prognosis in patients with heart failure with preserved ejection fraction[J]. Journal of Clinical Medicine in Practice, 2025, 29(5): 64-69. DOI: 10.7619/jcmp.20244630

Citation:

PDF (1020 KB)

Correlations of serum phosphoglycerate mutase family member 5 and YT521-B homology N6-methyladenosine RNA binding protein 2 levels with ventricular remodeling and prognosis in patients with heart failure with preserved ejection fraction

1.
Department of Cardiovascular Medicine, Xi'an Union Hospital, Xi'an, Shaanxi, 710199
2.
Department of Emergency, Xi'an Union Hospital, Xi'an, Shaanxi, 710199

More Information

Received Date: October 06, 2024
Revised Date: December 20, 2024

Graphical Abstract

Abstract

Abstract

Objective
To investigate the correlation between serum levels of phosphoglycerate mutase family member 5 (PGAM5) and YT521-B homology N6-methyladenosine RNA binding protein 2 (YTHDF2) with ventricular remodeling and prognosis in patients with heart failure with preserved ejection fraction (HFpEF).
Methods
A total of 175 HFpEF patients (HFpEF group) were selected as subjects, and 90 healthy volunteers undergoing physical examinations were chosen as the control group. The HFpEF patients were divided into adverse prognosis group (n=61) and favorable prognosis group (n=114) based on their prognosis status. Serum PGAM5 and YTHDF2 levels were measured using enzyme-linked immunosorbent assay. Ventricular remodeling indicators[left ventricular posterior wall thickness (LVPWT), left ventricular end-diastolic diameter (LVEDD), interventricular septal thickness at end-diastole (IVST) and left ventricular mass index (LVMI)] were assessed by transthoracic echocardiography. Pearson correlationanalysis was used to analyze the relationship between serum PGAM5 and YTHDF2 levels and ventricular remodeling indicators. The relationships of serum PGAM5 and YTHDF2 levels with the prognosis of HFpEF patients, as well as predictive efficacy, were evaluated using multivariate unconditional logistic regression analysis and receiver operating characteristic curve analysis, respectively.
Results
Levels of LVPWT, LVEDD, IVST, LVMI and YTHDF2 in the HFpEF group were significantly higher than those in the control group, while PGAM5 levels were significantly lower (P < 0.05). Serum PGAM5 levels in HFpEF patients showed negative correlations with LVPWT, LVEDD, IVST and LVMI, whereas YTHDF2 levels showed positive correlation (P < 0.05). The incidence of adverse prognosis among 175 HFpEF patients was 34.86% (61/175). Significant differences were observed in age, New York Heart Association (NYHA) heart function classification, N-terminal pro-B-type natriuretic peptide (NT-proBNP), LVPWT, LVEDD, IVST, LVMI, PGAM5 and YTHDF2 between the adverse prognosis group and favorable prognosis group. High levels of PGAM5 and YTHDF2 were independent protective and risk factors for adverse prognosis in HFpEF patients (P < 0.05). The area under the curve for predicting adverse prognosis in HFpEF patients using combined serum PGAM5 and YTHDF2 levels was 0.884, which was greater than the values obtained from individual predictions of 0.790 and 0.791 (Z=3.722, 3.373; P < 0.001).
Conclusion
Decreased serum PGAM5 levels and increased YTHDF2 levels are associated with worsening ventricular remodeling and poor prognosis in HFpEF patients. Combined measurement of serum PGAM5 and YTHDF2 levels shows high predictive efficacy for the prognosis of HFpEF patients.

FullText(HTML)

References (23)

References

[1]	射血分数保留的心力衰竭诊断与治疗中国专家共识制定工作组. 射血分数保留的心力衰竭诊断与治疗中国专家共识2023[J]. 中国循环杂志, 2023, 38(4): 375-393.
[2]	BENAK D, KOLAR F, HLAVACKOVA M. Epitranscriptomic regulations in the heart[J]. Physiol Res, 2024, 73(Suppl 1): S185-S198.
[3]	程高敏, 肖炜明. 磷酸甘油酸变位酶5的功能及其在疾病中的作用的研究进展[J]. 国际医药卫生导报, 2020, 26(18): 2830-2833.
[4]	LI S F, WEN P, ZHANG D Y, et al. PGAM5 expression levels in heart failure and protection ROS-induced oxidative stress and ferroptosis by Keap1/Nrf2[J]. Clin Exp Hypertens, 2023, 45(1): 2162537.
[5]	CHEN L, GAO Y, XU S M, et al. N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms[J]. Front Immunol, 2023, 14: 1162607.
[6]	ZHANG B J, XU Y M, CUI X T, et al. Alteration of m6A RNA methylation in heart failure with preserved ejection fraction[J]. Front Cardiovasc Med, 2021, 8: 647806.
[7]	中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2014[J]. 中国实用乡村医生杂志, 2015, 22(2): 6-12.
[8]	中华医学会超声医学分会超声心动图学组. 中国成年人超声心动图检查测量指南[J]. 中华超声影像学杂志, 2016, 25(8): 645-666.
[9]	吴秀娟, 林松, 马珂, 等. 心肺运动试验联合NT-proBNP在射血分数保留心力衰竭患者不良预后中的预测价值[J]. 中国循证心血管医学杂志, 2024, 16(2): 167-172.
[10]	中国医师协会急诊医师分会, 国家卫健委能力建设与继续教育中心急诊学专家委员会, 中国医疗保健国际交流促进会急诊急救分会. 急性冠脉综合征急诊快速诊治指南(2019)[J]. 中华急诊医学杂志, 2019, 28(4): 421-428. doi: 10.3760/cma.j.issn.1671-0282.2019.04.003
[11]	MADDOX T M, JANUZZI J L Jr, ALLEN L A, et al. 2024 ACC expert consensus decision pathway for treatment of heart failure with reduced ejection fraction: a report of the American college of cardiology solution set oversight committee[J]. J Am Coll Cardiol, 2024, 83(15): 1444-1488. doi: 10.1016/j.jacc.2023.12.024
[12]	苗艳丽, 李红净, 周海静, 等. 射血分数保留的心力衰竭患者血清Myostatin、DLL1与心室重构指标和预后的关系研究[J]. 国际检验医学杂志, 2024, 45(7): 841-846.
[13]	中国医师协会心力衰竭专业委员会, 国家心血管病专家委员会心力衰竭专业委员会, 中华心力衰竭和心肌病杂志编辑委员会, 等. 心力衰竭生物标志物临床应用中国专家共识[J]. 中华心力衰竭和心肌病杂志: 中英文, 2022, 6(3): 175-192.
[14]	GALLO G, RUBATTU S, VOLPE M. Mitochondrial dysfunction in heart failure: from pathophysiological mechanisms to therapeutic opportunities[J]. Int J Mol Sci, 2024, 25(5): 2667.
[15]	NORDGREN K K S, WALLACE K B. Disruption of the Keap1/Nrf2-antioxidant response system after chronic doxorubicin exposure in vivo[J]. Cardiovasc Toxicol, 2020, 20(6): 557-570.
[16]	FAN Z G, XU Y, CHEN X, et al. Appropriate dose of dapagliflozin improves cardiac outcomes by normalizing mitochondrial fission and reducing cardiomyocyte apoptosis after acute myocardial infarction[J]. Drug Des Devel Ther, 2022, 16: 2017-2030.
[17]	WANG Y L, REN T T, LI C Z, et al. Mechanisms involved in the regulation of mitochondrial quality control by PGAM5 in heart failure[J]. Cell Stress Chaperones, 2024, 29(3): 510-518.
[18]	ZHANG Y S, LIU Z Y, LIU Z Y, et al. m6A epitranscriptomic modification of inflammation in cardiovascular disease[J]. Int Immunopharmacol, 2024, 134: 112222.
[19]	江克兵, 徐璐晴, 沈涤非. 沉默YTH结构域家族蛋白2改善血管紧张素Ⅱ诱导的大鼠原代心肌细胞肥大与凋亡[J]. 中华老年心脑血管病杂志, 2024, 26(2): 202-206.
[20]	SHAO Y C, LI M M, YU Q, et al. CircRNA CDR1as promotes cardiomyocyte apoptosis through activating hippo signaling pathway in diabetic cardiomyopathy[J]. Eur J Pharmacol, 2022, 922: 174915.
[21]	SU J, HU Y C, CHENG J, et al. Comprehensive analysis of the RNA transcriptome expression profiles and construction of the CeRNA network in heart failure patients with sacubitril/valsartan therapeutic heterogeneity after acute myocardial infarction[J]. Eur J Pharmacol, 2023, 944: 175547.
[22]	YANG Y Q, MBIKYO M B, ZHANG J Z, et al. The lncRNA MIAT regulates CPT-1a mediated cardiac hypertrophy through m6A RNA methylation reading protein Ythdf2[J]. Cell Death Discov, 2022, 8(1): 167.
[23]	TANG Z Y, HUANG X, MEI H Y, et al. Silencing of METTL3 suppressed ferroptosis of myocardial cells by m6A modification of SLC7A11 in a YTHDF2 manner[J]. J Bioenerg Biomembr, 2024, 56(2): 149-157.

[1]	LIN Yuanchao, LIU Yiping. Effect of retroauricular injection of dexamethasone combined with intravenous drip of ginkgo biloba extract injection in treating sudden deafness[J]. Journal of Clinical Medicine in Practice, 2023, 27(8): 109-112. DOI: 10.7619/jcmp.20223850
[2]	WU Jianyue, NI Yingjie, RUI Yufeng, XU Lin, ZHANG Dong. A clinical analysis of hidden blood loss in elderly patients with intertrochanteric fracture of femur during perioperative period[J]. Journal of Clinical Medicine in Practice, 2022, 26(4): 60-63. DOI: 10.7619/jcmp.20213220
[3]	WANG Li, CONG Minghua, HE Ruixian, DONG Xue. Research progress on evaluation and nursing for loss of appetite in patients with tumor[J]. Journal of Clinical Medicine in Practice, 2021, 25(8): 117-123. DOI: 10.7619/jcmp.20201575
[4]	FENG Shuai, YANG Lihui, LI Weiguang, WANG Zhixiang, HUI Lian. Advances in research on the correlation between cadherin 23 and deafness[J]. Journal of Clinical Medicine in Practice, 2020, 24(13): 128-132. DOI: 10.7619/jcmp.202013036
[5]	QI Weiping, FENG Liang, MA Weihuan, JIANG Gongpeng. Effect of western medicine combined with traditional Chinese medicine in the treatment of sudden deafness[J]. Journal of Clinical Medicine in Practice, 2020, 24(11): 71-74. DOI: 10.7619/jcmp.202011020
[6]	XU Xiujian, LI Junrong, TENG Yuhuan. Clinical effect of Basozyme Injection combined with Butylphthalide Soft Capsules in the treatment of sudden deafness[J]. Journal of Clinical Medicine in Practice, 2020, 24(9): 13-15. DOI: 10.7619/jcmp.202009004
[7]	YAN Bin, TONG Xiaoyan. Analysis of influencing factors of prognosis in patients with sudden deafness[J]. Journal of Clinical Medicine in Practice, 2020, 24(6): 83-85. DOI: 10.7619/jcmp.202006023
[8]	LIU Fei, WANG Zhanjiang. Clinical effect of acoustic resonance combined with methylprednisolone injection in tympanum in treating patients with sudden deafness[J]. Journal of Clinical Medicine in Practice, 2019, 23(13): 85-88. DOI: 10.7619/jcmp.201913024
[9]	Effect of multidisciplinary cooperation on quality of life of presbycusis patients with hearing-aid[J]. Journal of Clinical Medicine in Practice, 2016, (22): 132-134,149. DOI: 10.7619/jcmp.201622041

Cited By

Cited by

Periodical cited type(7)

1.	陈凡杰，胡秀红，王萍. 超微血管成像联合剪切波弹性成像在乳腺影像学报告及数据系统4类结节诊断中的应用价值. 大医生. 2025(05): 123-125 .
2.	康林，刘喜，程浩，周金池，马鹏，窦维佳，刘震雄. 人工智能在早期食管癌内镜诊断中的应用进展. 空军军医大学学报. 2024(04): 465-471 .
3.	袁杰，汪成，笪应芬，吴林生. 联合应用二维、三维超微血管成像修正S-Detect分类良、恶性乳腺囊实性病变. 中国医学影像技术. 2024(04): 545-548 .
4.	袁杰，汪成，笪应芬. 萤火虫成像联合应变弹性成像校正人工智能S-Detect技术对乳腺囊实性肿块良恶性的诊断价值. 中国医疗器械杂志. 2024(04): 426-429+439 .
5.	丛小宇，笪应芬，胡佳飞，汪成. S-Detect技术辅助校正BI-RADS分类鉴别诊断乳腺黏液癌. 中华实用诊断与治疗杂志. 2024(09): 871-876 .
6.	钟树兴，郭红梅，刘美玲，王霞. 多模态超声联合人工智能S-Detect技术对BI-RADS 4类乳腺结节的诊断分析. 影像技术. 2024(05): 4-9+25 .
7.	叶绮婷，吴斯琪，孙秋水，张彩华，黄小玲，梁劲松. 人工智能S-Detect技术辅助诊断乳腺良恶性结节的应用价值. 影像研究与医学应用. 2023(24): 67-70 .

Other cited types(1)

Get Citation

PDF

XML

Article views (19) PDF downloads (2) Cited by(8)

Turn off MathJax

Article Contents

Abstract

References

Correlations of serum phosphoglycerate mutase family member 5 and YT521-B homology N6-methyladenosine RNA binding protein 2 levels with ventricular remodeling and prognosis in patients with heart failure with preserved ejection fraction